A study to evaluate the effectiveness and safety of changing from onabotulinum toxin A to abobotulinum toxin A in patients with focal hyperkinesias.
Phase of Trial: Phase IV
Latest Information Update: 22 Aug 2015
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- 22 Aug 2015 New trial record
- 18 Jun 2015 Results presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.